Sarika Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 04-12-2024
- Paid Up Capital ₹ 1.50 M
as on 04-12-2024
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.00 Cr
as on 04-12-2024
- Revenue 280.28%
(FY 2022)
- Profit 10839.52%
(FY 2022)
- Ebitda 2287.53%
(FY 2022)
- Net Worth 1243.03%
(FY 2022)
- Total Assets 213.66%
(FY 2022)
About Sarika Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹3.00 Cr.
Sanchita Sabharwal and Saksham Sabharwal serve as directors at the Company.
- CIN/LLPIN
U74999DL2017PTC320129
- Company No.
320129
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jul 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sarika Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanchita Sabharwal  | Director | 04-Jul-2017 | Current |
| Saksham Sabharwal | Director | 27-Jul-2021 | Current |
Financial Performance of Sarika Life Sciences.
Sarika Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 280.28% increase. The company also saw a substantial improvement in profitability, with a 10839.52% increase in profit. The company's net worth Soared by an impressive increase of 1243.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sarika Life Sciences?
In 2019, Sarika Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Synthesis Marketing Ventures Private LimitedActive 4 years 11 months
Saksham Sabharwal is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Apr 2024 | ₹3.00 Cr | Open |
How Many Employees Work at Sarika Life Sciences?
Unlock and access historical data on people associated with Sarika Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sarika Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sarika Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
